UBS AG Reaffirms “Buy” Rating for K2M Group Holdings, Inc. (KTWO)

K2M Group Holdings, Inc. (NASDAQ:KTWO)‘s stock had its “buy” rating reissued by stock analysts at UBS AG in a research report issued on Tuesday, www.benzinga.com reports. They presently have a $24.00 price target on the medical device company’s stock, down from their previous price target of $26.00. UBS AG’s target price indicates a potential upside of 35.06% from the stock’s current price.

A number of other equities research analysts have also issued reports on the company. Cowen and Company reissued a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research report on Wednesday, July 19th. Oppenheimer Holdings, Inc. reissued a “buy” rating on shares of K2M Group Holdings in a research report on Thursday, June 22nd. JMP Securities reissued an “outperform” rating and issued a $30.00 target price (up previously from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. Royal Bank Of Canada reissued a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research report on Thursday, July 20th. Finally, Needham & Company LLC reissued a “strong-buy” rating and issued a $27.00 target price (down previously from $29.00) on shares of K2M Group Holdings in a research report on Monday. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $26.10.

Shares of K2M Group Holdings (NASDAQ KTWO) traded up 2.392% during trading on Tuesday, hitting $18.195. The stock had a trading volume of 1,200,896 shares. K2M Group Holdings has a 1-year low of $16.32 and a 1-year high of $25.99. The company’s market capitalization is $787.26 million. The firm has a 50 day moving average of $22.10 and a 200 day moving average of $22.53.

K2M Group Holdings (NASDAQ:KTWO) last released its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.22) by $0.01. The company had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. K2M Group Holdings’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.27) earnings per share. Analysts expect that K2M Group Holdings will post ($0.81) EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.themarketsdaily.com/2017/10/10/k2m-group-holdings-inc-ktwo-pt-lowered-to-24-00-at-ubs-ag.html.

In other K2M Group Holdings news, insider John Philip Md Kostuik sold 1,332 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $23.30, for a total transaction of $31,035.60. Following the transaction, the insider now owns 200,629 shares of the company’s stock, valued at approximately $4,674,655.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Gregory S. Cole sold 2,350 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total value of $56,588.00. Following the transaction, the chief financial officer now directly owns 55,158 shares in the company, valued at approximately $1,328,204.64. The disclosure for this sale can be found here. Insiders have sold a total of 44,129 shares of company stock worth $1,033,644 in the last ninety days. Insiders own 5.80% of the company’s stock.

Large investors have recently bought and sold shares of the business. BNP Paribas Arbitrage SA increased its position in shares of K2M Group Holdings by 5,175.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock worth $109,000 after purchasing an additional 4,399 shares during the last quarter. Legal & General Group Plc increased its position in shares of K2M Group Holdings by 9.1% during the 1st quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock worth $138,000 after purchasing an additional 564 shares during the last quarter. Dorsey & Whitney Trust CO LLC acquired a new position in shares of K2M Group Holdings during the 2nd quarter worth approximately $211,000. American International Group Inc. increased its position in shares of K2M Group Holdings by 7.1% during the 1st quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock worth $325,000 after purchasing an additional 1,047 shares during the last quarter. Finally, Symphony Asset Management LLC acquired a new position in shares of K2M Group Holdings during the 2nd quarter worth approximately $351,000. 97.86% of the stock is currently owned by hedge funds and other institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply